老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lineage Cell Therapeutics Inc

0.9083
-0.0458-4.80%
盘后：0.90830.00000.00%19:30 EDT
成交量：178.47万
成交额：165.23万
市值：2.30亿
市盈率：-4.90
高：0.9700
开：0.9500
低：0.8950
收：0.9541
52周最高：2.09
52周最低：0.8823
股本：2.53亿
流通股本：1.91亿
量比：1.22
换手率：0.93%
股息：- -
股息率：- -
每股收益(TTM):-0.1855
每股收益(LYR):-0.2761
净资产收益率：-60.06%
总资产收益率：-17.04%
市净率：3.77
市盈率(LYR):-3.29

数据加载中...

总览公司新闻资讯公告
2020/05/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/10/18

重要事件披露

Current report, item 8.01
2019/10/15

重要事件披露

Current report, items 8.01 and 9.01
2019/09/19

重要事件披露

Current report, items 8.01 and 9.01
2019/09/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/12

重要事件披露

Current report, items 5.03, 8.01, and 9.01
2019/08/08

员工持股计划

Securities to be offered to employees in employee benefit plans
更多